GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Curatis Holding AG (CHIX:CURNz) » Definitions » Revenue

Curatis Holding AG (CHIX:CURNZ) Revenue : CHF0.00 Mil (TTM As of Dec. 2023)


View and export this data going back to 2013. Start your Free Trial

What is Curatis Holding AG Revenue?

Curatis Holding AG's revenue for the six months ended in Dec. 2023 was CHF0.00 Mil. Its revenue for the trailing twelve months (TTM) ended in Dec. 2023 was CHF0.00 Mil. Curatis Holding AG's Revenue per Share for the six months ended in Dec. 2023 was CHF0.00. Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was CHF0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.


Curatis Holding AG Revenue Historical Data

The historical data trend for Curatis Holding AG's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curatis Holding AG Revenue Chart

Curatis Holding AG Annual Data
Trend Dec21 Dec22 Dec23
Revenue
- - -

Curatis Holding AG Semi-Annual Data
Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Revenue Get a 7-Day Free Trial - - - - -

Competitive Comparison of Curatis Holding AG's Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Curatis Holding AG's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Curatis Holding AG's Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Curatis Holding AG's Revenue distribution charts can be found below:

* The bar in red indicates where Curatis Holding AG's Revenue falls into.



Curatis Holding AG Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was CHF0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Curatis Holding AG  (CHIX:CURNz) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Curatis Holding AG Revenue Related Terms

Thank you for viewing the detailed overview of Curatis Holding AG's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Curatis Holding AG (CHIX:CURNZ) Business Description

Traded in Other Exchanges
Address
Hochbergerstrasse 60C, Technologiepark Basel, Basel, CHE, 4057
Kinarus Therapeutics Holding AG In Liquidation Formerly Kinarus Therapeutics Holding AG is a clinical-stage pharmaceutical company focused on bringing novel treatments to patients suffering from viral, respiratory, and ophthalmic diseases. The company's therapeutic drug candidate, KIN001, consists of a clinical-stage p38 mitogen-activated protein kinase (p38 MAPK) inhibitor, in-licensed from Roche, combined with a marketed drug, together enabling an oral, long-term effective treatment for patients suffering from diseases with serious impact on quality of life.

Curatis Holding AG (CHIX:CURNZ) Headlines

No Headlines